Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,319,722
-$75,412,684 QoQ
Shares Held
54,377
-96.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#170
of 712 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. SNY ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in SNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,319,722 | 54,377 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $77,732,406 | 1,613,375 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $139,257,514 | 2,873,659 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $277,231,040 | 5,873,539 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $266,948,740 | 5,525,745 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $612,105,252 | 11,036,878 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $522,990,781 | 10,843,682 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $331,509,543 | 5,752,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $90,329,683 | 1,861,700 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $64,388,292 | 1,324,862 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $67,518,271 | 1,357,697 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $72,056,703 | 1,343,339 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $74,324,218 | 1,378,928 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $111,202,752 | 2,043,417 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $139,323,713 | 2,876,806 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $467,527,225 | 12,296,876 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $862,735,030 | 17,244,354 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $336,782,442 | 6,559,845 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $307,719,410 | 6,142,104 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $270,572,888 | 5,612,381 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $230,809,517 | 4,383,014 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $216,865,085 | 4,384,656 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $146,180,682 | 3,008,452 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $70,983,375 | 1,414,857 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $63,787,791 | 1,249,516 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||